[Treatment strategies for neonatal pulmonary morbidity in Europe].
OBJECTIVE
To survey practices in 14 European countries and to describe strategies for the prevention and treatment of pulmonary morbidity in very preterm newborns.


METHODS
Questionnaires covering the use of prenatal steroids, surfactant and postnatal steroids were sent in 1999-2000 to every neonatal unit taking very preterm newborns in charge in population-based areas covering at least 20,000 births annually. One questionnaire was sent by surveyed unit.


RESULTS
Results are given concerning these three treatments and compared to evidence based recommendations.


CONCLUSIONS
Antenatal steroids were given at recommended terms. Surfactant was prescribed with respect of best practices. Postnatal steroids utilisation was not well described.
Desnoulez
L
L
Service de médecine néonatale, hôpital Jeanne-de-Flandre, 59037 Lille, France. l-desnoulez@chru-lille.fr <l-desnoulez@chru-lille.fr>
Empana
J
J
Anceschi
M
M
Breart
G
G
Truffert
P
P
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D005060:Europe; D006801:Humans; D007231:Infant, Newborn; D008171:Lung Diseases / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D013501:Surface-Active Agents / Q000627:therapeutic use; D011795:Surveys and Questionnaires
D000305:Adrenal Cortex Hormones; D013501:Surface-Active Agents